BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31717460)

  • 1. DOCK1 Regulates Growth and Motility through the RRP1B-Claudin-1 Pathway in Claudin-Low Breast Cancer Cells.
    Chiang SK; Chang WC; Chen SE; Chang LC
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Dock1 and Elmo1 suppresses the migration and invasion of triple-negative breast cancer epithelial cells through the RhoA/Rac1 pathway.
    Liang Y; Wang S; Zhang Y
    Oncol Lett; 2018 Sep; 16(3):3481-3488. PubMed ID: 30127952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.
    Laurin M; Huber J; Pelletier A; Houalla T; Park M; Fukui Y; Haibe-Kains B; Muller WJ; Côté JF
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7434-9. PubMed ID: 23592719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer.
    Jääskeläinen A; Soini Y; Jukkola-Vuorinen A; Auvinen P; Haapasaari KM; Karihtala P
    BMC Cancer; 2018 Feb; 18(1):223. PubMed ID: 29482498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.
    Abd-Elazeem MA; Abd-Elazeem MA
    Ann Diagn Pathol; 2015 Feb; 19(1):37-42. PubMed ID: 25456318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
    Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
    Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition.
    Chen DJ; Chen W; Jiang H; Yang H; Wang YC; Chen JH
    Drug Des Devel Ther; 2016; 10():2845-2853. PubMed ID: 27660415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.
    Yang Y; Cheon S; Jung MK; Song SB; Kim D; Kim HJ; Park H; Bang SI; Cho D
    Biochem Biophys Res Commun; 2015 Apr; 459(3):379-86. PubMed ID: 25727011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOCK1 inhibition suppresses cancer cell invasion and macropinocytosis induced by self-activating Rac1
    Tomino T; Tajiri H; Tatsuguchi T; Shirai T; Oisaki K; Matsunaga S; Sanematsu F; Sakata D; Yoshizumi T; Maehara Y; Kanai M; Cote JF; Fukui Y; Uruno T
    Biochem Biophys Res Commun; 2018 Feb; 497(1):298-304. PubMed ID: 29432733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
    Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
    J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Zhang G; Zhang J; Yang X; Zhang X; Yang S; Wang J; Hu K; Shi J; Ke X; Fu L
    Cancer Manag Res; 2019; 11():3053-3060. PubMed ID: 31114350
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression and delocalization of claudin-3 protein in MCF-7 and MDA-MB-415 breast cancer cell lines.
    Todd MC; Petty HM; King JM; Piana Marshall BN; Sheller RA; Cuevas ME
    Oncol Lett; 2015 Jul; 10(1):156-162. PubMed ID: 26170992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
    Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
    Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-7 modulates cell-matrix adhesion that controls cell migration, invasion and attachment of human HCC827 lung cancer cells.
    Kim DH; Lu Q; Chen YH
    Oncol Lett; 2019 Mar; 17(3):2890-2896. PubMed ID: 30854065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chromatin remodeling protein BRM regulates the transcription of tight junction proteins: Implication in breast cancer metastasis.
    Yang Y; Liu L; Fang M; Bai H; Xu Y
    Biochim Biophys Acta Gene Regul Mech; 2019 May; 1862(5):547-556. PubMed ID: 30946989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis.
    Bhat AA; Pope JL; Smith JJ; Ahmad R; Chen X; Washington MK; Beauchamp RD; Singh AB; Dhawan P
    Oncogene; 2015 Aug; 34(35):4570-80. PubMed ID: 25500541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin sensitizes human non-small-cell lung carcinomas to gefitinib by inhibiting DOCK1 expression, vimentin phosphorylation, and Akt activation.
    Pan Y; Li X; Duan J; Yuan L; Fan S; Fan J; Xiaokaiti Y; Yang H; Wang Y; Li X
    Mol Pharmacol; 2015; 87(3):378-90. PubMed ID: 25488183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-apoptotic effect of Δ2-TGZ in "claudin-1-low" triple-negative breast cancer cells: involvement of claudin-1.
    Geoffroy M; Kleinclauss A; Grandemange S; Hupont S; Boisbrun M; Flament S; Grillier-Vuissoz I; Kuntz S
    Breast Cancer Res Treat; 2017 Oct; 165(3):517-527. PubMed ID: 28681173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway.
    Liu W; Chen G; Sun L; Zhang Y; Han J; Dai Y; He J; Shi S; Chen B
    Front Oncol; 2019; 9():617. PubMed ID: 31338333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.